Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ancient scraping therapy timed to Body's clock may tackle back pain

NCT ID NCT07754422

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial tests whether adding Gua Sha—a traditional scraping therapy—to standard care can improve pain and function in people with lumbar disc herniation. The therapy is applied to the bladder meridian during the 'Shen period' (3–5 p.m.), based on traditional Chinese medicine's body-clock theory. Researchers will compare outcomes like pain scores, lumbar function, and levels of the inflammation marker CRP between a group receiving standard care and a group receiving standard care plus Gua Sha. The study enrolls 128 adults who are not suitable for surgery and have recurrent symptoms.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Gua Sha therapy (scraping) applied to the bladder meridian during the Shen period (3-5 p.m.)
What this could lead to
If effective, this could offer a non-drug, low-cost add-on therapy to reduce pain and improve mobility in people with lumbar disc herniation.
What could go wrong
This is a single-center trial with a modest sample size, and results may not generalize. Gua Sha can cause skin bruising or discomfort, and its benefits over standard care alone are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

128 people

The number who actually took part.

Started

Jan 2023

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients meeting the diagnostic criteria for LDH according to Traditional Chinese Medicine and Western Medicine * Stable vital signs and absence of severe complications, including concomitant severe cardiovascular, cerebrovascular, hepatic, renal, or hematological diseases * Patients able to cooperate with the entire course of treatment and sign an informed consent form * Patients unsuitable for surgery and experiencing recurrent episodes following treatment Exclusion Criteria: * Participants unable to continue treatment * Participants developing other serious illnesses during the trial * Participants whose symptoms worsen to the point that emergency measures are required

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lumbar disc herniation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Intervertebral Disc Displacement lumbar disk disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine

    Foshan, GuanDongSheng, 528200, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.